Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-6.85	10.96	11.77
Graham Fair Price	39.92	31238.11	22325.88
PEG	-70.19	0.04	-0.12
Price/Book	11.52	0.25	0.23
Price/Cash Flow	-57.73	20.38	48.22
Prices/Earnings	-42.76	3.51	6.14
Price/Sales	35.16	0.75	0.55
Price/FCF	-57.73	20.38	48.22
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.63	0.20	0.20
Operating Margin	26.20	0.11	0.09
ROA	89.47	< 0.005	< 0.005
ROE	< 0.005	0.02	94.82
ROIC	0.02	0.02	23.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	-0.03	73.08
Dividends QOQ	4.48	-1.00	-77.67
EBIT QOQ	-0.26	0.04	-82.92
EPS QOQ	-0.50	0.95	92.04
FCF QOQ	5.74	1.64	-71.33
Revenue QOQ	0.17	-0.17	1.44
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	32.60	42.35	29.90
Days Sales Outstanding (DSO)	69.52	80.14	15.27
Inventory Turnover	2.76	2.13	-23.02
Debt/Capitalization	0.33	0.34	3.11
Quick Ratio	1.31	1.24	-5.49
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	48962.43	49081.49	0.24
Cash	13409.83	16017.26	19.44
Capex	-1901.86	-1419.47	25.36
Free Cash Flow	230.41	609.33	164.45
Revenue	20134.28	16653.13	-17.29
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.67	1.58	-5.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.13	5.93	-16.77
Naive Interpretation	Member

06 - Financial Health · Weak

Rating